From bcabd2cfa710c35bf847ffe7dfcddb9ff42bf8f4 Mon Sep 17 00:00:00 2001 From: Borja Robert Date: Thu, 21 Mar 2024 15:26:28 +0100 Subject: [PATCH] [logseq-plugin-git:commit] 2024-03-21T14:26:27.074Z --- pages/STOP2030___Web___Posts.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/pages/STOP2030___Web___Posts.md b/pages/STOP2030___Web___Posts.md index ad6ed27b..61591414 100644 --- a/pages/STOP2030___Web___Posts.md +++ b/pages/STOP2030___Web___Posts.md @@ -5,7 +5,7 @@ - #+BEGIN_VERSE At STOP2030 we want to provide a pharmacological tool that helps at delivering WHO's elimination goals for soil-transmitted helminthiasis (STH). We are happy to announce that we've completed the design of the REALISE study (Real world Evaluation of an ALbendazol-Ivermectin coformulation Safety and Effectiveness), our largest clinical trial. - The details of the REALISE study have been published in ClinicalTrials.gov and the Pan African Clinical Trial Registry. These details and will be delivered soon to the Institutional Review Boards (IRBs) in Ghana and Kenya, the two countries where the clinical phase of the trial will be carried out. + The details of the REALISE study have been published in ClinicalTrials.gov and the Pan African Clinical Trial Registry. These details will soon be shared with the Institutional Review Boards (IRBs) in Ghana and Kenya, the two countries where the clinical phase of the trial will be carried out. The design of the clinical trial was lead by the teams at ISGlobal and Liconsa, with help from other members of our Consortium. The study itself is a Cohort Event Study aimed at evaluating the safety and effectiveness of our fixed-dose coformulation (FDC) of albendazol and ivermectin within large populations, matched against the standard dose albendazole currently in use against STH. We expect to recruit around 20 thousand school-aged children between 5 and 17 years old between the two countries.